New Finger-Prick test could revolutionize dialysis timing
NCT ID NCT07450534
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a new way of measuring kidney function (using an injection of iohexol and finger-prick blood tests) can better predict when people with advanced kidney disease will start feeling sick from kidney failure. It also checks if this method can accurately measure remaining kidney function in people already on dialysis. About 150 adults with stage 4 or 5 chronic kidney disease or on dialysis will take part. The goal is to see if this test is more useful than current standard methods.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE (STAGES 4 AND 5) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Manchester Royal infirmary
Manchester, M13 9WL, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A softer path for kidney disease: could palliative care ease the burden?
- Can a 30-hour e-learning course equip family doctors to deliver better palliative care?
- Gut health supplement may calm inflammation in kidney dialysis patients
- Creatine and exercise during dialysis: a new hope for kidney patients?
- Thyroid hormones may hold clues to kidney disease progression
- Curcumin drink may ease inflammation in kidney dialysis patients